JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Stress and Vision Fluctuations in Retinitis Pigmentosa

Completed

Conditions: Retinitis Pigmentosa

First Posted Date: 2007-05-21

Last Posted Date: 2011-04-06

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 50

Registration Number: NCT00475254

Locations: 🇺🇸
Johns Hopkins WiImer Eye Insitute's Lions Vision Center, Baltimore, Maryland, United States

Validation of Esophageal Variceal Grading: A Comparative Study of Upper Gastrointestinal (GI) Endoscopy and Capsule Endoscopy

Not Applicable

Withdrawn

Conditions: Esophageal and Gastric Varices

Interventions: Device: Esophageal Capsule Endoscopy
Device: Upper Gastrointestinal Endoscopy

First Posted Date: 2007-05-21

Last Posted Date: 2017-07-24

Lead Sponsor: Johns Hopkins University

Registration Number: NCT00475592

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Intervention Study to Control High Blood Pressure for Korean American

Not Applicable

Completed

Conditions: High Blood Pressure

First Posted Date: 2007-05-15

Last Posted Date: 2008-05-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 445

Registration Number: NCT00473681

Locations: 🇺🇸
Korean Resource Center, Ellicott city, Maryland, United States

Innovative Approaches to Tuberculosis Control

Completed

Conditions: Tuberculosis

First Posted Date: 2007-05-11

Last Posted Date: 2017-08-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 1000

Registration Number: NCT00472316

Locations: 🇧🇷
The Health Department of Rio de Janeiro, Brazil, Rio de Janeiro, Brazil

Particulate Reduction Education in City Homes

Phase 3

Completed

Conditions: Asthma

Interventions: Behavioral: Health Coach and HEPA air cleaners

First Posted Date: 2007-04-27

Last Posted Date: 2015-09-01

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 125

Registration Number: NCT00466024

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Psychopharmacology of Psilocybin in Cancer Patients

Phase 2

Completed

Conditions: Depressive Symptoms
Anxiety
Cancer

Interventions: Drug: psilocybin

First Posted Date: 2007-04-25

Last Posted Date: 2018-07-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 56

Registration Number: NCT00465595

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Campus, Baltimore, Maryland, United States

A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk Allergy

Phase 1

Completed

Conditions: Milk Hypersensitivity

Interventions: Other: Placebo
Drug: cow's milk powder

First Posted Date: 2007-04-25

Last Posted Date: 2017-04-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 20

Registration Number: NCT00465569

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States

Domestic Violence Enhanced Home Visitation Program (DOVE)

Phase 2

Completed

Conditions: Domestic Violence

Interventions: Behavioral: Public Health Nurse Home Visit
Behavioral: Intimate Partner Violence (IPV) Protocol

First Posted Date: 2007-04-25

Last Posted Date: 2015-04-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 239

Registration Number: NCT00465556

Locations: 🇺🇸
Missouri Department of Health and Senior Services; Missouri Community Based Home Visiting Program and Lutheran and Family Children's Services in Columbia and Springfield, Columbia, Missouri, United States
🇺🇸
Baltimore City Health Department, Baltimore, Maryland, United States

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

Phase 4

Terminated

Conditions: Asthma

Interventions: Drug: Mometasone
Drug: Advair

First Posted Date: 2007-04-18

Last Posted Date: 2017-09-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 33

Registration Number: NCT00461812

Locations: 🇺🇸
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States

Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine

Phase 1

Terminated

Conditions: Mycobacterium Tuberculosis

Interventions: Drug: Moxifloxacin
Drug: Rifapentine

First Posted Date: 2007-04-16

Last Posted Date: 2017-12-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 15

Registration Number: NCT00460759

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy